We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$278M
AUM Growth
-$148M
Cap. Flow
-$149M
Cap. Flow %
-53.67%
Top 10 Hldgs %
51.03%
Holding
53
New
6
Increased
12
Reduced
16
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.49M
2
COR icon
Cencora
COR
+$6.02M
3
A icon
Agilent Technologies
A
+$4.89M
4
BIIB icon
Biogen
BIIB
+$4.34M
5
BRKR icon
Bruker
BRKR
+$3.01M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$28.5M
2
CRL icon
Charles River Laboratories
CRL
+$6.77M
3
INSP icon
Inspire Medical Systems
INSP
+$5.91M
4
ABT icon
Abbott
ABT
+$5.68M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.02M

Sector Composition

Rank Sector Weight
1 Healthcare 80.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.06T
$13.6M 4.88%
15,000
-1,000
-6% -$800K
NVO
2
Novo Nordisk
NVO
$203B
$12.8M 4.61%
90,000
-2,500
-3% -$331K
MCK icon
3
McKesson
MCK
$102B
$10.5M 3.78%
18,000
+3,500
+24% +$1.95M
THC icon
4
Tenet Healthcare
THC
$20.7B
$9.31M 3.34%
70,000
-5,000
-7% -$602K
BSX icon
5
Boston Scientific
BSX
$71.4B
$8.86M 3.18%
115,000
-20,000
-15% -$1.46M
SYK icon
6
Stryker
SYK
$129B
$8.51M 3.06%
25,000
– –
MRK icon
7
Merck
MRK
$317B
$8.15M 2.93%
+65,874
New +$8.49M
HCA icon
8
HCA Healthcare
HCA
$88.5B
$8.03M 2.88%
25,000
+7,500
+43% +$2.44M
ISRG icon
9
Intuitive Surgical
ISRG
$132B
$7.79M 2.8%
17,500
-2,500
-13% -$996K
TMO icon
10
Thermo Fisher Scientific
TMO
$214B
$7.74M 2.78%
14,000
-1,500
-10% -$859K
DHR icon
11
Danaher
DHR
$141B
$7.5M 2.69%
30,000
– –
UHS icon
12
Universal Health Services
UHS
$10.3B
$7.4M 2.66%
40,000
– –
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$123B
$7.03M 2.53%
15,000
+4,000
+36% +$1.74M
BIIB icon
14
Biogen
BIIB
$30.5B
$6.96M 2.5%
30,000
+19,966
+199% +$4.34M
SGRY icon
15
Surgery Partners
SGRY
$1.95B
$5.95M 2.14%
250,000
+60,000
+32% +$1.54M
CAH icon
16
Cardinal Health
CAH
$55.7B
$5.9M 2.12%
60,000
+15,000
+33% +$1.53M
COR icon
17
Cencora
COR
$63.2B
$5.86M 2.1%
+26,000
New +$6.02M
BDX icon
18
Becton Dickinson
BDX
$48.8B
$5.84M 2.1%
25,000
+10,000
+67% +$2.36M
RMD icon
19
ResMed
RMD
$32.4B
$5.74M 2.06%
30,000
-5,361
-15% -$1.09M
EW icon
20
Edwards Lifesciences
EW
$51.5B
$5.54M 1.99%
60,000
-10,000
-14% -$886K
ACHC icon
21
Acadia Healthcare
ACHC
$2.86B
$5.4M 1.94%
80,003
+10,003
+14% +$699K
AVTR icon
22
Avantor
AVTR
$8.91B
$5.3M 1.9%
250,000
+36,053
+17% +$868K
SEM
23
DELISTED
Select Medical
SEM
$5.08M 1.83%
269,120
-102,080
-28% -$1.74M
PODD icon
24
Insulet
PODD
$9.65B
$5.04M 1.81%
25,000
-5,000
-17% -$901K
EHC icon
25
Encompass Health
EHC
$12.4B
$4.72M 1.69%
55,000
-5,000
-8% -$420K
1
2 3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return
MFG
Macco Financial Group Green Bay, Wisconsin $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM

Sivik Global Healthcare's Q2 2024 Portfolio in Review

As of Q2 2024, Sivik Global Healthcare held 53 positions worth $278M, down 35% from $427M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sivik Global Healthcare withdrew a net $149M in Q2 2024, closing 15 positions and reducing 16 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $28.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 58% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in Merck worth $8.15M.

  • Sivik Global Healthcare's largest Q2 2024 buy was Merck: 65,874 shares worth $8.15M.
  • Sivik Global Healthcare added most to Biogen in Q2 2024, an estimated $4.34M increase.
  • Sivik Global Healthcare's biggest Q2 2024 reduction was Humana, cutting an estimated $4.22M.
  • Sivik Global Healthcare fully exited State Street SPDR S&P Biotech ETF in Q2 2024, selling an estimated $28.5M.
  • Sivik Global Healthcare's ten largest holdings make up 51% of its $278M portfolio in Q2 2024.
  • Sivik Global Healthcare opened 6 new positions and closed 15 in Q2 2024.
  • Sivik Global Healthcare's portfolio value fell 35% quarter-over-quarter to $278M.

Based on Sivik Global Healthcare's 13F filing for Q2 2024, filed 29 Jul 2024.